INVITRO SELECTION OF VARIANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANT TO 3'-AZIDO-3'-DEOXYTHYMIDINE AND 2',3'-DIDEOXYINOSINE

被引:152
作者
GAO, Q
GU, ZX
PARNIAK, MA
LI, XG
WAINBERG, MA
机构
[1] SIR MORTIMER B DAVIS JEWISH HOSP,LADY DAVIS INST,3755 CHEMIN COTE STE CATHERINE,MONTREAL H3T 1E2,QUEBEC,CANADA
[2] MCGILL UNIV,MCGILL AIDS CTR,MONTREAL H3A 2T5,QUEBEC,CANADA
关键词
D O I
10.1128/JVI.66.1.12-19.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Drug-resistant variants of human immunodeficiency virus type 1 (HIV-1) have been isolated by in vitro selection. MT-4 cells were infected with either a laboratory strain (HIV-III(B)) or a clinical isolate (no. 187) of HIV-1 and maintained in medium containing subeffective concentrations of the drugs 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxyinosine (ddI). By gradually increasing the drug concentration in the culture medium during propagation of the virus on fresh MT-4 cells, we were able to isolate variants of HIV-III(B) and clinical isolate 187 which showed up to 100-fold increases in resistance to the drugs. The drug resistance phenotypes remained stable after propagation of the variants in the absence of drug pressure for over 2 months. However, variants resistant to one drug showed little or no cross-resistance to the other, suggesting that the genetic bases for resistance to the compounds differed. Genotypic analysis of these nucleoside-resistant variants by polymerase chain reaction (PCR) with primer pairs previously shown to correspond to mutations responsible for resistance to AZT was also carried out. A heterogeneity of genotypes was observed, with known mutations at pol codons 70 and 215 occurring in most of the AZT-resistant variants generated from either HIV-III(B) or clinical strain 187. However, mutations in codons 67 and 219 were less frequently detected, and none of these changes were observed in each of four variants resistant to ddI. Cloning and sequencing studies of the reverse transcriptase coding region of two of the isolates were also performed and confirmed the PCR data that had been obtained. In addition to previously described mutation sites responsible for resistance to AZT, and HIV-III(B)-resistant variant was shown to be mutated at positions 108 (Val --> Ala) and 135 (Ile --> Thr), while a resistant variant of strain 187 was mutated at positions 50 (Ile --> Val) and 135 (Ile --> Val).
引用
收藏
页码:12 / 19
页数:8
相关论文
共 41 条
  • [1] A HUMAN CYTOMEGALOVIRUS MUTANT RESISTANT TO THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE (BW B759U) INDUCES REDUCED LEVELS OF BW B759U TRIPHOSPHATE
    BIRON, KK
    FYFE, JA
    STANAT, SC
    LESLIE, LK
    SORRELL, JB
    LAMBE, CU
    COEN, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) : 8769 - 8773
  • [2] HIGH-FREQUENCY OF ISOLATION OF DEFECTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND HETEROGENEITY OF VIRAL GENE-EXPRESSION IN CLONES OF INFECTED U-937 CELLS
    BOULERICE, F
    BOUR, S
    GELEZIUNAS, R
    LVOVICH, A
    WAINBERG, MA
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (04) : 1745 - 1755
  • [3] CHARACTERIZATION OF A DNA-POLYMERASE MUTANT OF HERPES-SIMPLEX VIRUS FROM A SEVERELY IMMUNOCOMPROMISED PATIENT RECEIVING ACYCLOVIR
    COLLINS, P
    LARDER, BA
    OLIVER, NM
    KEMP, S
    SMITH, IW
    DARBY, G
    [J]. JOURNAL OF GENERAL VIROLOGY, 1989, 70 : 375 - 382
  • [4] ACTIVITY INVITRO AGAINST HERPES-VIRUS OF 9-(2-HYDROXYETHOXYMETHYL)GUANINE (ACYCLOGUANOSINE), A NEW ANTI-VIRAL AGENT
    COLLINS, P
    BAUER, DJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1979, 5 (04) : 431 - 436
  • [5] CRUMPACKER CS, 1989, NEW ENGL J MED, V321, P163, DOI 10.1056/NEJM198907203210306
  • [6] MOLECULAR-CLONING AND PRIMARY NUCLEOTIDE-SEQUENCE ANALYSIS OF A DISTINCT HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATE REVEAL SIGNIFICANT DIVERGENCE IN ITS GENOMIC SEQUENCES
    DESAI, SM
    KALYANARAMAN, VS
    CASEY, JM
    SRINIVASAN, A
    ANDERSEN, PR
    DEVARE, SG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) : 8380 - 8384
  • [7] PROGRESSIVE DISEASE DUE TO GANCICLOVIR-RESISTANT CYTOMEGALO-VIRUS IN IMMUNOCOMPROMISED PATIENTS
    ERICE, A
    CHOU, S
    BIRON, KK
    STANAT, SC
    BALFOUR, HH
    JORDAN, MC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) : 289 - 293
  • [8] THE EFFICACY OF AZIDOTHYMIDINE (AZT) IN THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    FISCHL, MA
    RICHMAN, DD
    GRIECO, MH
    GOTTLIEB, MS
    VOLBERDING, PA
    LASKIN, OL
    LEEDOM, JM
    GROOPMAN, JE
    MILDVAN, D
    SCHOOLEY, RT
    JACKSON, GG
    DURACK, DT
    KING, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) : 185 - 191
  • [9] AZIDOTHYMIDINE ASSOCIATED WITH BONE-MARROW FAILURE IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS)
    GILL, PS
    RARICK, M
    BRYNES, RK
    CAUSEY, D
    LOUREIRO, C
    LEVINE, AM
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 107 (04) : 502 - 505
  • [10] INFECTION OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I (HTLV-I)-BEARING MT-4 CELLS WITH HTLV-III (AIDS VIRUS) - CHRONOLOGICAL STUDIES OF EARLY EVENTS
    HARADA, S
    KOYANAGI, Y
    YAMAMOTO, N
    [J]. VIROLOGY, 1985, 146 (02) : 272 - 281